09:56 EDT Adlai Nortye Ltd (ADR) trading resumes
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANL:
- Adlai Nortye to Unveil Cancer Drug Data at ASCO 2024
- Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
- Adlai Nortye announces first patient dosed in Phase II trial of palupiprant
- Adlai Nortye Ltd (ADR) trading resumes
- Adlai Nortye Ltd (ADR) trading halted, volatility trading pause